Max Financial Services

Investment case

Fastest-growing private life insurer

Why this business

Listed holding company whose only material asset is an ~80% stake in Axis Max Life Insurance, India's fourth-largest private life insurer with a 10.4% private-sector market share (FY26, +56 bps), FY26 gross written premium of Rs 38,877 crore and embedded value of Rs 28,871 crore (Mar-2026). Axis Bank and affiliates own 19.99% and provide the dominant bancassurance channel (65-70% counter share at Axis branches); the group has board approval to reverse-merge MFSL into Axis Max Life and list the insurer directly by Apr-2027. Consolidated reported PAT (Rs 106 cr in FY26) is not meaningful - the stock is valued on P/EV and VNB.

What we believe

1. 01Fastest VNB compounder among listed private lifers: FY26 VNB Rs 2,647 cr (+26%) vs HDFC Life +2%, ICICI Pru +11%, SBI Life +12%; Q1FY27 VNB +33% with margin up 290 bps to 23.2%.
2. 02Growth ahead of the market: Q1FY27 APE +15% and FY26 individual adjusted FYP +19% (private share up 56 bps to 10.4%); two-year individual APE CAGR of ~13.1% is the best among the four listed private peers (BusinessToday, Sep-2026).
3. 03Product mix upgrade driving margin: protection & health +44%, annuity +116%, par +48% in Q1FY27; PL forecasts VNB margin of 25.0%/25.1% for FY27/FY28 vs 25.2% delivered in FY26.
4. 04Structure catalyst: board-approved reverse merger of MFSL into Axis Max Life with direct listing targeted by 5-Apr-2027 removes the holdco discount and the 26.9% promoter pledge overhang; Axis Bank evaluating a rise to 30% (cost ~Rs 3,900 cr for 10.01%) under RBI's Dec-2025 master directions, cementing the bancassurance partnership.
5. 05EV compounding: EV Rs 30,415 cr (+15% YoY), operating RoEV 14.9%, solvency 198% with a Rs 1,600 cr QIP approval in hand until May-2027 that management says is not currently needed.

Why now

On the metric that matters: ~1.9x FY27E / 1.6x FY28E P/EV per Nuvama (Sep-2026) at Rs 1,526, vs SBI Life 1.8x/1.5x and HDFC Life 1.6x/1.4x; MFSL's market cap of Rs 52,140 cr against Rs 30,415 cr EV (Jun-2026, 100% basis; MFSL owns ~80%) equates to ~2.1x look-through trailing EV. Own 5y average P/EV not sourced. EV/EBITDA n.m.; dividend yield 0.0%.

Market disagreement

• HDFC Life: HDFC Life (59x PE, 6x P/B, ROE 11.3%; Nuvama P/EV 1.6x/1.4x) grew FY26 VNB only 2% vs Axis Max Life +26% and has a larger base; the ~0.3x P/EV premium on MFSL buys 2-3x the VNB growth plus the structure-simplification catalyst.
• ICICI Prudential Life: ICICI Pru is the cheapest (1.1x/1.0x FY27/28E P/EV, 42x PE, Q1FY27 PAT -19%) but has had a -1.7% two-year individual APE CAGR and a weaker banca engine; MFSL's 13% two-year APE CAGR and 33% VNB growth justify paying up.

Position sizing

Core Mid cap  2.9% of the PMS on $31 Jul 2026 (August rank 10). Core positions are owned through the cycle for leadership and cash-flow quality.

Catalysts

• Filing of the composite scheme of amalgamation with NCLT/IRDAI (no formal scheme filed as of Aug-2026); direct listing of Axis Max Life targeted 5-Apr-2027.
• RBI/board decision on Axis Bank raising its stake from 19.99% to 30% (evaluation announced Jul-2026, ~Rs 3,900 cr).
• H1FY27 results (Nov-2026): VNB margin holding above 24% and APE growth above 15% would support the 1.9x FY27E P/EV.

Risks and response

• Holdco/structure risk: the merger needs IRDAI approval and Axis consent, with an NCLT process of 6-12 months after filing; failure to list Axis Max Life by Apr-2027 (swap deadline Jul-2027) could trigger an IPO or exit-sale fallback.
• Bancassurance concentration: Axis Bank contributes the bulk of APE (65-70% counter share); any regulatory cap on banca open architecture or Axis re-prioritising would hit growth. Axis channel APE grew 14% in Q1FY27, below company-level 15%.
• Margin sensitivity to ULIP/GST: ITC withdrawal after the Sep-2025 GST exemption is absorbed by insurers, and a market-linked slowdown in ULIPs (+19% in Q1FY27) or adverse surrender-value rules would pressure the 25% margin path.

Thesis-break conditions

Not stated separately on this page; the risk list carries the monitoring triggers.

Review history

• 8 Sep 2026 · Yash Palod · one-pager in "Why We Own What We Own" (p37) · portfolio as of $31 Jul 2026
• 31 Aug 2026 · Classification in the August top-30: Core

Source: Buoyant_Why_We_Own_What_We_Own_Sep2026.pdf (portfolio as of 31 July 2026), p37. Internal; external publication of these fields is controlled by audience policy.